Amikacin nebulization for the adjunctive therapy of gram-negative pneumonia in mechanically ventilated patients: a systematic review and meta-analysis of randomized controlled trials
Abstract Treatment of ventilated patients with gram-negative pneumonia (GNP) is often unsuccessful. We aimed to assess the efficacy and safety of nebulized amikacin (NA) as adjunctive therapy to systemic antibiotics in this patient population. PubMed, Embase, China national knowledge infrastructure,...
Guardado en:
Autores principales: | Jun-Ping Qin, Hui-Bin Huang, Hua Zhou, Yuan Zhu, Yuan Xu, Bin Du |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a62b370790684b078b22fea15bd00d9a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Characteristics of Carbapenem-Resistant Gram-Negative Bacilli in Patients with Ventilator-Associated Pneumonia
por: Amira Mohamed, et al.
Publicado: (2021) -
Inhaled amikacin versus placebo to prevent ventilator-associated pneumonia: the AMIKINHAL double-blind multicentre randomised controlled trial protocol
por: Sigismond Lasocki, et al.
Publicado: (2021) -
Heteroresistance to Amikacin in Carbapenem-Resistant Klebsiella pneumoniae Strains
por: Feiyang Zhang, et al.
Publicado: (2021) -
Emergence of blaNDM-1 and blaVIM producing Gram-negative bacilli in ventilator-associated pneumonia at AMR Surveillance Regional Reference Laboratory in India.
por: Mithlesh Kumari, et al.
Publicado: (2021) -
Multifunctional nanoagents for ultrasensitive imaging and photoactive killing of Gram-negative and Gram-positive bacteria
por: Jiali Tang, et al.
Publicado: (2019)